{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T14:33:53Z","timestamp":1774103633476,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jmii.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T23:33:09Z","timestamp":1431559989000},"page":"232-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk factors for sepsis-related death in children and adolescents with hematologic and malignant diseases"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-4602","authenticated-orcid":false,"given":"Hirozumi","family":"Sano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2015.04.002_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0195-6701(97)90091-8","article-title":"Central venous catheter-related septicaemia in paediatric cancer patients","volume":"36","author":"Das","year":"1997","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2015.04.002_bib2","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.ejca.2005.04.037","article-title":"A prospective study of septicaemia on a paediatric oncology unit: a three-year experience at The Royal Liverpool Children's Hospital, Alder Hey, UK","volume":"41","author":"Paulus","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmii.2015.04.002_bib3","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.ejca.2009.06.003","article-title":"Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting","volume":"45","author":"Dommett","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmii.2015.04.002_bib4","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/pbc.24995","article-title":"Invasive bacterial and fungal infections in paediatric patients with cancer: Incidence, risk factors, aetiology and outcomes in a UK regional cohort 2009\u20132011","volume":"61","author":"Calton","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jmii.2015.04.002_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jmii.2015.04.002_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jmii.2015.04.002_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MPH.0b013e31815acae0","article-title":"Risk factors for death in children and adolescents with cancer and sepsis\/septic shock","volume":"30","author":"da Silva","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jmii.2015.04.002_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MPH.0b013e31819daf4a","article-title":"Piperacillin\/tazobactam plus ceftazidime versus sulbactam\/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients","volume":"31","author":"Kobayashi","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jmii.2015.04.002_bib9","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/pbc.21692","article-title":"A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders","volume":"51","author":"Sato","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jmii.2015.04.002_bib10","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/pbc.25148","article-title":"A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients","volume":"61","author":"Sarashina","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jmii.2015.04.002_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/pbc.25178","article-title":"Comparison between piperacillin\/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: a prospective, randomized study","volume":"62","author":"Sano","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jmii.2015.04.002_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmii.2015.04.002_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-9343(80)90243-0","article-title":"Improved prognosis for granulocytopenic patients with gram-negative bacteremia","volume":"68","author":"Love","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jmii.2015.04.002_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","article-title":"A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia","volume":"315","author":"Pizzo","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2015.04.002_bib15","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2001.19.14.3415","article-title":"Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever","volume":"19","author":"Santolaya","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmii.2015.04.002_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/342064","article-title":"Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia","volume":"35","author":"Santolaya","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.04.002_bib17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/INF.0b013e318124aa44","article-title":"Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode","volume":"26","author":"Santolaya","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2015.04.002_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/pbc.24158","article-title":"Biomarkers for risk stratification of febrile neutropenia among children with malignancy: a pilot study","volume":"59","author":"Mian","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jmii.2015.04.002_bib19","first-page":"593","article-title":"Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever","volume":"12","author":"Penel","year":"2004","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jmii.2015.04.002_bib20","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1097\/INF.0b013e31829ae38d","article-title":"An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer","volume":"32","author":"Haeusler","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2015.04.002_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2015.04.002_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.04.002_bib23","first-page":"197","article-title":"Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan","volume":"36","author":"Lai","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.jmii.2015.04.002_bib24","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2015.04.002_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0924-8579(99)00172-7","article-title":"Viridans-group streptococcal infections in immunocompromised hosts","volume":"14","author":"Shenep","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2015.04.002_bib26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2000.18.9.1845","article-title":"Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's Cancer Group study CCG-2891","volume":"18","author":"Gamis","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411821500746X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411821500746X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:51Z","timestamp":1761657651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168411821500746X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S168411821500746X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2015.04.002","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for sepsis-related death in children and adolescents with hematologic and malignant diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}